301 related articles for article (PubMed ID: 29946875)
1. [Pathophysiology and treatment of IgA nephropathy].
Bollin R; Haller H
Internist (Berl); 2018 Jul; 59(7):736-740. PubMed ID: 29946875
[TBL] [Abstract][Full Text] [Related]
2. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
3. Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits complicated by immunoglobulin A nephropathy in the renal allograft.
Sawada A; Kawanishi K; Horita S; Koike J; Honda K; Ochi A; Komoda M; Tanaka Y; Unagami K; Okumi M; Shimizu T; Ishida H; Tanabe K; Nagashima Y; Nitta K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():48-52. PubMed ID: 26971743
[TBL] [Abstract][Full Text] [Related]
4. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
Floege J
Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
[TBL] [Abstract][Full Text] [Related]
5. Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining.
Ştefan G; Ismail G; Stancu S; Zugravu A; Andronesi A; Mandache E; Mircescu G
Pathol Int; 2016 Aug; 66(8):453-9. PubMed ID: 27439692
[TBL] [Abstract][Full Text] [Related]
6. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
Trimarchi H; Coppo R
Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study.
Kamano C; Shimizu A; Joh K; Hashiguchi A; Hisano S; Katafuchi R; Kawamura T;
Clin Exp Nephrol; 2021 May; 25(5):509-521. PubMed ID: 33595730
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy.
Katafuchi R; Nagae H; Masutani K; Tsuruya K; Mitsuiki K
Clin Exp Nephrol; 2019 Feb; 23(2):169-181. PubMed ID: 30066158
[TBL] [Abstract][Full Text] [Related]
9. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
Segarra A
Nefrologia; 2010; 30(5):501-7. PubMed ID: 20882091
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.
Mizerska-Wasiak M; Małdyk J; Rybi-Szumińska A; Wasilewska A; Miklaszewska M; Pietrzyk J; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Pukajło-Marczyk A; Zwolińska D; Szczepańska M; Turczyn A; Roszkowska-Blaim M
Pediatr Nephrol; 2015 Jul; 30(7):1113-20. PubMed ID: 25549975
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant immunoglobulin A deposition and nephropathy in allografts.
Sofue T; Suzuki H; Ueda N; Kushida Y; Minamino T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():4-9. PubMed ID: 29968406
[TBL] [Abstract][Full Text] [Related]
12. Infantile immunoglobulin A nephropathy showing features of membranoproliferative glomerulonephritis.
Kurosu A; Oka N; Hamaguchi T; Yoshikawa N; Joh K
Tohoku J Exp Med; 2012 Nov; 228(3):253-8. PubMed ID: 23089637
[TBL] [Abstract][Full Text] [Related]
13. Collectin11 and Complement Activation in IgA Nephropathy.
Wei M; Guo WY; Xu BY; Shi SF; Liu LJ; Zhou XJ; Lv JC; Zhu L; Zhang H
Clin J Am Soc Nephrol; 2021 Dec; 16(12):1840-1850. PubMed ID: 34615657
[TBL] [Abstract][Full Text] [Related]
14. Role of complement in IgA nephropathy.
Daha MR; van Kooten C
J Nephrol; 2016 Feb; 29(1):1-4. PubMed ID: 26567162
[TBL] [Abstract][Full Text] [Related]
15. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort.
Meng H; Zhang L; E X; Ye F; Li H; Han C; Yamakawa M; Jin X
Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568
[TBL] [Abstract][Full Text] [Related]
16. IgA nephropathy and significance of immunostaining data.
Nasri H
Iran J Immunol; 2013 Dec; 10(4):267-9. PubMed ID: 24375068
[No Abstract] [Full Text] [Related]
17. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic tests and treatment options in glomerular disease: 2014 update.
Hogan J; Mohan P; Appel GB
Am J Kidney Dis; 2014 Apr; 63(4):656-66. PubMed ID: 24239051
[TBL] [Abstract][Full Text] [Related]
19. Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy.
Kang Y; Xu B; Shi S; Zhou X; Chen P; Liu L; Li Y; Leng Y; Lv J; Zhu L; Zhang H
Clin J Am Soc Nephrol; 2023 Dec; 18(12):1583-1591. PubMed ID: 37651123
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and pathological features of IgA nephropathy in west Guangdong province].
Chen WL; Lin HP; Liu HF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1150-1. PubMed ID: 20501418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
